News from rosetta genomics

Jun 13, 2013, 12:30 ET

Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Novitas...

Jun 07, 2013, 08:30 ET

Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has...

Jun 06, 2013, 08:30 ET

Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a manuscript...

Jun 04, 2013, 08:30 ET

Rosetta Genomics to Increase the Number of U.S. Sales Territories

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces plans to expand its...

May 28, 2013, 08:30 ET

Rosetta Genomics Announces Presence at ASCO 2013

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company...

May 22, 2013, 08:30 ET

Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A....

May 20, 2013, 08:30 ET

Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that...

May 10, 2013, 08:30 ET

Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of $625,000...

May 07, 2013, 08:30 ET

Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announces that the...

Apr 18, 2013, 09:00 ET

Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the...

Apr 02, 2013, 09:56 ET

Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that two posters related...

Apr 01, 2013, 08:00 ET

Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a...

Mar 25, 2013, 08:30 ET

Rosetta Genomics To Host Business Update Conference Call on April 10, 2013

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced...

Mar 18, 2013, 08:30 ET

Rosetta Genomics Receives 25th U.S. Patent Allowance

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of a Notice...

Mar 12, 2013, 09:13 ET

Rosetta Genomics to Present at the 25th Annual Roth Conference

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Ken Berlin,...

Feb 14, 2013, 08:30 ET

Rosetta Genomics Receives Two Key U.S. Patent Allowances

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the...

Feb 07, 2013, 09:00 ET

Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a...

Jan 30, 2013, 09:42 ET

Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the Company...

Jan 09, 2013, 08:30 ET

Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a...

Jan 04, 2013, 08:30 ET

Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Kenneth...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge